CHRYSANTHI SARDELI

Scopus Publications

Protective Efficacy of Selenium in Cisplatin-Induced Retinal Toxicity: An Experimental Immunohistochemical and Ultrastructural Analysis
Ioannis Konstantinidis, Sophia Tsokkou, Pavlos Pavlidis, Kyriaki Papadopoulou, Dimitrios Kavvadas, et al.
Nutrients, 2026
Background/Objectives: Cisplatin is a potent chemotherapeutic agent whose clinical utility is limited by severe side effects, including neurotoxicity affecting the ocular system. The pathophysiology involves oxidative stress and mitochondrial dysfunction, to which the retina is particularly vulnerable. Selenium (Se), an essential trace element and component of antioxidant enzymes, has shown potential in mitigating cisplatin toxicity, although its efficacy with respect to retinal structure and the influence of administration routes remain underexplored. This study aimed to evaluate the protective efficacy of selenium against cisplatin-induced retinal toxicity and compare the effects of intraperitoneal and oral selenium administration. Methods: Forty adult male Wistar rats were randomized into four groups (n = 10 each): Group A (Cisplatin Monotherapy, 3.5 mg/kg IP for 5 days; cumulative dose 17.5 mg/kg); Group B (Cisplatin + Intraperitoneal Selenium, 2.73 mg/kg; cumulative dose 60 mg/kg); Group C (Control); and Group D (Cisplatin + Oral Selenium). Selenium prophylaxis, administered as sodium selenite (Na2SeO3), began two days prior to cisplatin administration and continued for 15 days post-treatment. Retinal evaluation two weeks after cisplatin cessation included light microscopy, semi-quantitative immunohistochemical (IHC) analysis for inflammatory (IL-6) and fibrotic (TGF-β2) markers, and Transmission Electron Microscopy (TEM) for ultrastructural analysis, which were the primary endpoints. Statistical differences in the IHC scores were analyzed via the Kruskal-Wallis H test with Dunn’s post hoc comparisons. Results: Cisplatin monotherapy (Group A) caused severe disruption of the retinal architecture, including edema, reactive gliosis, and significant upregulation of IL-6 and TGF-β2. Ultrastructural analysis revealed mitochondrial swelling (cristolysis) and photoreceptor disk fragmentation. Intraperitoneal selenium (Group B) was associated with significant structural preservation and intact mitochondria, with TGF-β2 levels comparable to those of the controls, although the IL-6 level remained moderately elevated. Conversely, oral selenium (Group D) suppressed both IL-6 and TGF-β2 expression to near-negative levels but provided less ultrastructural protection, resulting in persistent mitochondrial swelling and focal photoreceptor disruption. Conclusions: Systemic cisplatin induces severe subcellular retinal toxicity characterized by mitochondrial damage and photoreceptor degeneration. Selenium supplementation attenuates these effects; however, outcome patterns differ by administration route. Intraperitoneal selenium was associated with greater morphological and ultrastructural preservation despite persistent IL-6 elevation, whereas oral selenium normalized immunohistochemical marker expression to near-control levels but was associated with more pronounced residual subcellular damage on qualitative TEM assessment. These preliminary morphological and immunohistochemical findings suggest that the route of selenium delivery may influence its neuroprotective profile; however, pharmacokinetic measurements and functional retinal assessments, such as electroretinography, are warranted before its clinical translation.
Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand?
Chara Tsiampali, Iordanis Vagiakis, Chrysanthi Sardeli, Anastasios G. Konstas
Advances in Therapy, 2026
Correction Clinical Efficacy of Prolotherapy for Temporomandibular Joint Disorders: A Systematic Review and Meta-Analysis (Clinics and Practice, (2025), 15, 3, (51), 10.3390/clinpract15030051)
Antonios Saramantos, Athanassios Kyrgidis, Gregorios Venetis, Georgios Hatziantoniou, Anestis Chrysostomidis, et al.
Clinics and Practice, 2026
In the original publication [...]
Artificial Intelligence–Driven Wearable and Connected Technology for Allergy: Real-Time Monitoring and Predictive Management for Personalized Care
George N. Konstantinou, William C. Anderson, Evangelos Bagkis, Zoe Brown, Kostas Karatzas, et al.
Journal of Allergy and Clinical Immunology in Practice, 2025
Innovative Educational Tools Facilitating Lifestyle and Nutritional Interventions in Type 1 Diabetes Mellitus
Christos Daramilas, Maria Papagianni, Christina Ntafi, George Mastorakos, Chrysanthi Sardeli
Nutrients, 2025
Background/Objectives: Education plays a crucial role in encouraging and aiding diabetic patients to take active responsibility for the day-to-day management of their condition and can reduce disease burden, thus minimizing the risk of complications, as well as morbidity and mortality. Lack of information increases the chances of diabetes complications. Methods: A combination of conceptual allegory and group presentation of experiences using appropriate, tailor-made, educational material was applied. To better support the trainees, maps for diabetes education were created, an educational tool that gathers roles and procedures, guiding diabetic patients in their self-care and supporting them in being able to develop coping mechanisms and self-manage their disease. The educational material was used during educational sessions held in three Greek cities. The effect of patient education was measured using specifically developed questionnaires at two time points, namely, before and after the implementation of the intervention. Results: The results showed that training using innovative educational tools had a positive effect on the lifestyle and nutrition of diabetic patients, as their health indicators improved, (significant decreases in HbA1c, incidents of severe hypoglycemia, and emotional distress, as well as improvements in self-reported hypoglycemia awareness and wellbeing were observed), without changes in the prescribed pharmacotherapy. Conclusions: The need for structured educational courses on self-management for individuals with T1DM is indisputable. The main objective of such a program should be the motivation of patients to be actively involved in the prevention and management of both diabetes and its complications.
Clinical Efficacy of Prolotherapy for Temporomandibular Joint Disorders: A Systematic Review and Meta-Analysis
Antonios Saramantos, Athanassios Kyrgidis, Gregorios Venetis, Georgios Hatziantoniou, Anestis Chrysostomidis, et al.
Clinics and Practice, 2025
Background: Temporomandibular disorders (TMDs) encompass a group of conditions characterized by anatomical, histological, and/or functional abnormalities that affect the muscular and/or articular components of the temporomandibular joint. Prolotherapy is an injectable treatment modality for chronic musculoskeletal pain that involves dextrose solution administration in the joint. Aims: To summarize, the aims involve considering the existing quality of clinical evidence on the efficacy of prolotherapy versus placebo and other active comparators, such as autologous blood products or botulinum toxin, in improving the outcomes of TMDs. Methods: A literature search in MEDLINE, Scopus, and Cochrane databases was performed, following the PRISMA statement guidelines, to identify randomized controlled trials (RCTs) of patients with TMDs receiving prolotherapy. The maximal incisor opening (MIO), visual analogue score (VAS) for pain, and frequency of dislocations were analyzed as the outcomes. The weighted mean difference was used to pool outcomes. The risk of bias was recorded for the included studies. Results: Six studies comparing prolotherapy to placebo were identified. Prolotherapy is uniformly more efficient in reducing the VAS for pain when compared to the placebo (mean difference = 1.20, 95%CI: 0.56–1.84, p < 0.001). Perceived jaw mobility was improved among prolotherapy patients, (mean difference = 0.47, 95%CI: 0.05–0.90, p = 0.003) when compared to the placebo. A beneficial effect for prolotherapy with regard to MIO (mean difference = 0.84, 95%CI: −2.12–3.80, p = 0.58) was not confirmed. Prolotherapy appears to be more efficient than autologous blood products in reducing VAS for pain (mean difference = 0.49, 95%CI: 0.11–0.87, p = 0.01). Prolotherapy was found to be more effective in reducing pain, MIO, and clicking when compared to an occlusal splint in a single study. Conclusions: Prolotherapy is also a promising modality for TMDs, despite the limited number of randomized clinical trials. Existing evidence supports its use to reduce TMD-related pain, even against other modalities. Further research is needed to better describe the benefit of prolotherapy for other outcomes.
Role of Memantine in Limiting Cochleotoxicity in Rats
Pavlos Pavlidis, Vasilis Spyridon Tseriotis, Kyriaki Papadopoulou, Sophia Karachrysafi, Chrysanthi Sardeli, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery, 2024
Οur aim was to test whether amikacin’s well-known cochleotoxic effects could be suppressed, depending on whether an NMDA-antagonist (memantine) was administered simultaneously with or after amikacin treatment. Forty Wistar rats were used in this experiment. Ten rats acted as controls and received no medication (group A). Amikacin (200 mg/kg) was administered intraperitoneally (i.p.) once daily for 14 days to 10 animals in group B; amikacin (200 mg/kg) was administered concurrently with memantine (10 mg/kg, i.p., once daily) to the same 10 animals in group C. Group D was given intraperitoneal memantine (10 mg/kg, once daily) for 14 days following a 2-week amikacin treatment. The cochlear activity of the right ear was tested using DPOAE in conscious animals. All animals were sacrificed at the conclusion of the experiment and both cochleae were collected for histological and immunohistochemical analysis. All groups treated with amikacin showed decreased cochlear activity, as testified by decreased DPOAE-amplitudes compared to the pre-treatment state. In the rats of group B, the DPOAE reduction was more pronounced. On histologic exam, the cochlear structures of group C rats and, although to a lesser extent, group D rats showed less severe cochlea damage. Memantine plays a protective role, resulting in restoring partially cochlear structures when administered either simultaneously with or after completion of amikacin i.p. treatment in rats.
Sentinel Lymph Node Staging in Early-Stage Cervical Cancer: A Comprehensive Review
Chrysoula Margioula-Siarkou, Aristarchos Almperis, Giuseppe Gullo, Emmanouela-Aliki Almperi, Georgia Margioula-Siarkou, et al.
Journal of Clinical Medicine, 2024
Cervical cancer (CC) continues to be a significant global public health concern, even with preventive measures in place. In women with early-stage CC, the status of lymph nodes is of paramount importance, not only for the final prognosis but also for determining the best therapeutic strategy. According to main international guidelines, pelvic full lymphadenectomy (PLND) is recommended for lymph node staging. However, in these early stages of CC, sentinel lymph node biopsy (SLNB) has emerged as a precise technique for evaluating lymph node involvement, improving its morbidity profile. We performed a literature review through PubMed articles about progress on the application of SLNB in women with early-stage CC focusing on the comparison with PET/CT and PLND in terms of oncological outcomes and diagnostic accuracy. While the superiority of SLNB is clear compared to radiologic modalities, it demonstrates no clear oncologic inferiority over PLND, given the higher detection rate of positive lymph nodes and predominance of no lymph node recurrences. However, due to a lack of prospective evidence, particularly concerning long-term oncological safety, SLNB is not the current gold standard. With careful patient selection and adherence to straightforward protocols, a low false-negative rate can be ensured. The aim of the ongoing prospective trials is to address these issues.
Chronic Obstructive Pulmonary Disease and Non-Small Cell Lung Cancer an association
Paul Zarogoulidis, Rena Oikonomidou, Dimitris Petridis, Haidong Huang, Chong Bai, et al.
Journal of Cancer, 2024
Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo
Paul Zarogoulidis, Dimitris Petridis, Haidong Huang, Chong Bai, Georgia Pitsiou, et al.
Journal of Cancer, 2024
Salicylate- and Noise-induced Tinnitus. Different Mechanisms Producing the same Result? An Experimental Model
Pavlos Pavlidis, Kyriaki Papadopoulou, Vasilis Spyridon Tseriotis, Sophia Karachrysafi, Chrysanthi Sardeli, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery, 2023
Pharmacologic Stewardship in a Rural Community Pharmacy
Chrysanthi Sardeli, Theodoros Athanasiadis, Eleni Stamoula, Dimitrios Kouvelas
Healthcare Switzerland, 2023
Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: A laboratory experiment
Paul Zarogoulidis, Dimitris Petridis, Haidong Huang, Chong Bai, Panagoula Oikonomou, et al.
Therapeutic Delivery, 2023
Epithelial Ovarian Cancer: A Five Year Review
Christos Arnaoutoglou, Kalliopi Dampala, Christos Anthoulakis, Evangelos G. Papanikolaou, Ioannis Tentas, et al.
Medicina Lithuania, 2023
Positron Emission-Computed Tomography, Cryobiopsy versus Bronchoalveolar Lavage and Computed Tomography Findings for Interstitial Lung Disease: A Long-Term Follow-Up
Paul Zarogoulidis, Dimitris Matthaios, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, et al.
Medicina Lithuania, 2023
Immunotherapy for the elderly. Maybe the best option for lung cancer?
Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, et al.
Cancer Treatment and Research Communications, 2023
Sotorasib after immune checkpoint inhibitor administration induces hepatotoxicity. True, false or just another adverse effect of NSCLC treatment
Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, et al.
Cancer Treatment and Research Communications, 2023
Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and Cons
Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Wei Chen, Konstantinos Porpodis, Christoforos Kosmidis, et al.
Journal of Cancer, 2023
Review Factors Affecting the Nuclei in Newborn and Children
Christos Arnaoutoglou, Anastasia Keivanidou, Georgios Dragoutsos, Ioannis Tentas, Soultana Meditskou, et al.
International Journal of Environmental Research and Public Health, 2022
Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
Paul Zarogoulidis, Christoforos Kosmidis, Eleni-Isidora Perdikouri, Wolfgang Hohemforst-Schmidt, Chrisanthi Sardeli
Respiratory Medicine Case Reports, 2022
A health condition index for assessing disease progression
Dimitris Petridis, Dimitris Matthaios, Vaggelis Christakidis, Chrysanthi Sardeli, Lutz Freitag, et al.
Expert Review of Respiratory Medicine, 2022
Airway local endoscopic pharmacological treatment; current applications and future concepts
Paul Zarogoulidis, Christoforos Kosmidis, Konstantinos Sapalidis, Wolfgang Hohenforst-Schmidt, Dimitris Matthaios, et al.
Frontiers in Bioscience Landmark, 2022
Modification Tadalafil and Macitentan tablets to aerosol
Paul Zarogoulidis, Dimitris Petridis, Chrysa Sardeli, Christoforos Kosmidis, Kosmas Tsakiridis, et al.
Frontiers in Bioscience Landmark, 2022
Modification of apremilast from pills to aerosol a future concept
Paul Zarogoulidis, Christoforos Kosmidis, Nikolaos Kougkas, Aimilios Lallas, Dimitris Petridis, et al.
International Journal of Environmental Research and Public Health, 2021
Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
Eleni Stamoula, Spyridon Siafis, Ioannis Dardalas, Alexandra Ainatzoglou, Alkis Matsas, et al.
Frontiers in Immunology, 2021
Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series
Daliborka Bursac, Bojan Zarić, Tomi Kovačević, Vladimir Stojšić, Anastasios Vagionas, et al.
Case Reports in Oncology, 2021
PD-L1 and standardized uptake value expression in lung cancer: A possible connection for efficient early lung cancer treatment
Paul Zarogoulidis, Chrysanthi Sardeli, Vagelis Christakidis, Wolfgang Hohenforst-Schmidt, Haidong Huang, et al.
Biomarkers in Medicine, 2021
Intratumoral treatment with chemotherapy and immunotherapy for NSCLC with EBUS-TBNA 19G
Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Jun Zhou, Qin Wang, et al.
Journal of Cancer, 2021
Interventional bronchoscopy for HPV 16 and 66 with the use of spraying interferon-α (2b) plus bevacizumab and anti-reflux agent
Paul Zarogoulidis, Dimitris Hatzibougias, Kosmas Tsakiridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, et al.
Respiratory Medicine Case Reports, 2021
Priority of PET-CT vs CT thorax for EBUS-TBNA 22G vs 19G: Mesothorax lymphadenopathy
Paul Zarogoulidis, Haidong Huang, Zhenli Hu, Ning Wu, Jiannan Wang, et al.
Journal of Cancer, 2021
Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study
Paul Zarogoulidis, Dimitris Petridis, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, et al.
Expert Review of Respiratory Medicine, 2021
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination
Paul Zarogoulidis, Vagelis Christakidis, Dimitris Petridis, Konstantinos Sapalidis, Chriforos Kosmidis, et al.
Expert Review of Respiratory Medicine, 2021
Producing the appropriate model and drug for intratumoural ablation
Christoforos Kosmidis, Chrysanthi Sardeli, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Anastasios Vagionas, et al.
British Journal of Cancer, 2020
Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer
Chrysanthi Sardeli, Paul Zarogoulidis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantinos Sapalidis, et al.
Respiratory Medicine Case Reports, 2020
Sex differences and adverse effects between chemotherapy and immunotherapy for non-small cell lung cancer
Theodora Tsiouda, Chrisanthi Sardeli, Konstantinos Porpodis, Maria Pilikidou, Georgios Apostolidis, et al.
Journal of Cancer, 2020
Pleurodesis and immunotherapy in NSCLC; Medical thoracoscopy or VATS?
Paul Zarogoulidis, Haidong Huang, Meng Yang, Jun Zhou, Yang Jiao, et al.
Journal of Cancer, 2020
Pharmacologic and non-pharmacologic interventions for hiv-neuropathy pain. A systematic review and a meta-analysis
Aikaterini Amaniti, Chrysanthi Sardeli, Varvara Fyntanidou, Panagiota Papakonstantinou, Ioannis Dalakakis, et al.
Medicina Lithuania, 2019
Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review
Ioannis Tsakiridis, Vasiliki Bousi, Themistoklis Dagklis, Chrysanthi Sardeli, Vasiliki Nikolopoulou, et al.
Archives of Gynecology and Obstetrics, 2019
Inhaled cisplatin for NSCLC: Facts and results
Christoforos Kosmidis, Konstantinos Sapalidis, Paul Zarogoulidis, Chrysanthi Sardeli, Charilaos Koulouris, et al.
International Journal of Molecular Sciences, 2019
Genes’ interactions: A major contributor to the malignant transformation of endometriosis
Konstantinos Sapalidis, Nikolaos Machairiotis, Paul Zarogoulidis, Sofia Vasilakaki, Chrysanthi Sardeli, et al.
International Journal of Molecular Sciences, 2019
Targeted nanotechnology from bench to bedside
Konstantinos Sapalidis, Christoforos Kosmidis, Stela Laskou, Athanasios Katsaounis, Stylianos Mantalobas, et al.
Current Cancer Drug Targets, 2019
Scar tissue to lung cancer; pathways and treatment
Konstantinos Sapalidis, Chrysanthi Sardeli, Efstathios Pavlidis, Georgios Koimtzis, Charilaos Koulouris, et al.
Journal of Cancer, 2019
Update on current pancreatic treatments: From molecular pathways to treatment
Konstantinos Sapalidis, Christoforos Kosmidis, Varvara Funtanidou, Athanasios Katsaounis, Amastasios Barmpas, et al.
Journal of Cancer, 2019
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE®
Konstantinos Sapalidis, Paul Zarogoulidis, Dimitris Petridis, Christoforos Kosmidis, Barbara Fyntanidou, et al.
Journal of Cancer, 2019
Conventional Versus Therapeutic Stents for Airway Malignancies: Novel Local Therapies Underway
Paul Zarogoulidis, Chrysanthi Sardeli, Fotis Konstantinou, Konstantinos Sapalidis
Ebiomedicine, 2018
Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: Tumor mutation burden and PD-L1 ≥50%
Paul Zarogoulidis, Vasilis Papadopoulos, Elena Maragouli, George Papatsibas, Chrysanthi Sardeli, et al.
Translational Lung Cancer Research, 2018
Psoriatic arthritis due to nivolumab administration a case report and review of the literature
Konstantinos Sapalidis, Christoforos Kosmidis, Nikolaos Michalopoulos, Charilaos Koulouris, Stylianos Mantalobas, et al.
Respiratory Medicine Case Reports, 2018
Beware of hemopneumothorax following core needle breast biopsy
Nikos Schizas, Achileas Lazopoulos, Dimitris Krimiotis, Thomas Rallis, Dimitris Paliouras, et al.
Respiratory Medicine Case Reports, 2018
Lung cancer induced from chemotherapy a 20 years old case
Konstantinos Sapalidis, Stella Laskou, Aikaterini Amaniti, Stylianos Mantalovas, Dimitris Giannakidis, et al.
Respiratory Medicine Case Reports, 2018
Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases
Konstantinos Sapalidis, Nikos Schizas, Achileas Lazopoulos, Parthena Kamparoudi, Dimitris Paliouras, et al.
Respiratory Medicine Case Reports, 2018
Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS)
Paul Zarogoulidis, Stella Laskou, Athanasios Katsaounis, Efstathios Pavlidis, Dimitrios Giannakidis, et al.
Respiratory Medicine Case Reports, 2018
Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: In vivo Study. A more efficient combination
Konstantinos Sapalidis, Paul Zarogoulidis, Efstathios Pavlidis, Stella Laskou, Athanasios Katsaounis, et al.
Journal of Cancer, 2018
Inhaled immunotherapy administration for lung cancer; efficient? Certainly possible
Konstantinos Sapalidis, Paul Zarogoulidis, Haidong Huang, Chong Bai, Yuting Wen, et al.
Journal of Cancer, 2018
Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires
Ioannis Tremmas, George Petsatodis, Michael Potoupnis, Stella Laskou, Dimitrios Giannakidis, et al.
Journal of Cancer, 2018
The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country
Jelena Perin, Bojan Zarić, Jelica Eremić Đođić, Zoran Potić, Marijela Potić, et al.
Journal of Cancer, 2018
Second-line afatinib administration in an elderly patient with squamous cell carcinoma
Wolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Michael Steinheimer, Naim Benhassen, Chrysanthi Sardeli, et al.
Therapeutics and Clinical Risk Management, 2017
The role of sarcosine, uracil, and kynurenic acid metabolism in urine for diagnosis and progression monitoring of prostate cancer
Georgios Gkotsos, Christina Virgiliou, Ioanna Lagoudaki, Chrysanthi Sardeli, Nikolaos Raikos, et al.
Metabolites, 2017
Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series
Paul Zarogoulidis, Aggeliki Rapti, Chrysanthi Sardeli, Panagiotis Chinelis, Anastasia Athanasiadou, et al.
Respiratory Medicine Case Reports, 2017
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
Paul Zarogoulidis, Haidong Huang, Theodora Tsiouda, Chrysa Sardeli, Georgia Trakada, et al.
Respiratory Medicine Case Reports, 2017
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
Paul Zarogoulidis, Panos Chinelis, Anastasia Athanasiadou, Theodora Tsiouda, Georgia Trakada, et al.
Respiratory Medicine Case Reports, 2017
Pregabalin abuse after past substanceseeking behavior
Georgios Papazisis, Georgios Garyfallos, Chrysanthi Sardeli, Dimitrios Kouvelas
International Journal of Clinical Pharmacology and Therapeutics, 2013
Endometriosis: The role of pharmacotherapy
Chrysanthi Sardeli, Angelos Daniilidis, Antonios Goulas, Georgios Papazisis, Dimitrios Kouvelas, et al.
Current Women S Health Reviews, 2012
Surgical treatment of endometriosis
George Michalopoulos, Vassilios Makris, Angelos Daniilidis, Chrysanthi Sardeli, Konstantinos Dinas, et al.
Current Women S Health Reviews, 2012
Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: An open-labeled randomized trial
Michael Chourdakis, Michaela M. Kraus, Thrasivoulos Tzellos, Chrysanthi Sardeli, Maria Peftoulidou, et al.
Journal of Parenteral and Enteral Nutrition, 2012
Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: A systematic review and meta-analysis
TG Tzellos, C Sardeli, A Lallas, G Papazisis, M Chourdakis, et al.
Journal of the European Academy of Dermatology and Venereology, 2011
Pregnancy-associated breast cancer - A review analysis
European Journal of Gynaecological Oncology, 2010
Possible interactions with drugs of herbals used for weight loss enhancement
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2010
Safety and tolerability of α2δ ligand gabapentin in treating hot flashes: An evidence-based systematic review and meta-analysis
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2010
Self-prescribing: A common phenomenon especially among young Greek doctors
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2010
Safety/tolerability of α2δ ligand pregabalin in the treatment of fibromyalgia: An evidence based evaluation
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2010
Long term effects of oxcarbazepine in brain hypoxiaischemia: A study in neonatal rats
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2010
Verification of the accuracy of cervical cytology reports in women referred for colposcopy
European Journal of Gynaecological Oncology, 2010
A2δ ligands gabapentin and pregabalin: Future implications in daily clinical practice
Hippokratia, 2010
D-dimer levels as a predicting factor for DIC following single twin death: A case report and review of the literature
Clinical and Experimental Obstetrics and Gynecology, 2010
D-dimer levels following single twin death: A case report and review of the literature
A. Daniilidis, C. Sardeli, K. Dinas, T. Tantanasis, J. Tzafettas
European Journal of Obstetrics and Gynecology and Reproductive Biology, 2010
PDE5 inhibitors: In vitro and in vivo pharmacological profile
D. Kouvelas, A. Goulas, G. Papazisis, C. Sardeli, C. Pourzitaki
Current Pharmaceutical Design, 2009
Effects of fentanyl administration on the release of glutamate in the rat posterior hypothalamus
Epitheorese Klinikes Farmakologias Kai Farmakokinetikes, 2009
Evidence-based evaluation of emergency care treatment algorithms: 15 Dominant myths
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2008
Pregabalin combined with epidural analgesia in chronic cancer pain patients
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2008
Pregabalin as a new treatment strategy for neuropathic pain in spinal cord injury: An evidence based evaluation
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2008
Deciding on the best treatment strategy for recurrent febrile seizures: An evidence-based medicine approach
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2008
Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia
Georgios Papazisis, Chryssa Pourzitaki, Chrysanthi Sardeli, Aimilios Lallas, Ekaterini Amaniti, et al.
Pharmacological Research, 2008
Outcome of site-specific fascia repair for rectocele
CHRYSANTHI SARDELI, SUSANNE M. AXELSEN, DANIEL KJÆR, KARL M. BEK
Acta Obstetricia Et Gynecologica Scandinavica, 2007
α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction
Chunling Li, Yimin Shi, Weidong Wang, Chrysanthi Sardeli, Tae-Hwan Kwon, et al.
American Journal of Physiology Renal Physiology, 2006
Use of porcine small intestinal submucosa in the surgical treatment of recurrent rectocele in a patient with Ehlers-Danlos syndrome type III
Chrysanthi Sardeli, Susanne M. Axelsen, Karl M. Bek
International Urogynecology Journal, 2005
Changes in the Micturition Profile and Bladder AQP3 after Ovariectomy in Rats
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2004
Upregulation of Renal Water Channels and Sodium Transporters in Response to Ovariectomy in Rats
Review of Clinical Pharmacology and Pharmacokinetics International Edition, 2004
Renal aquaporins and sodium transporters with special focus on urinary tract obstruction
APMIS Supplement, 2003
The effect of antifreeze glycoproteins on survival of fish spermatozoa under the conditions of long-term storage at 4°C
M. V. Karanova, N. D. Pronina, L. I. Tsvetkova
Biology Bulletin, 2002
Compliance and viewpoint of glaucoma patients in Greece
A G P Konstas, G Maskaleris, S Gratsonidis, C Sardelli
Eye, 2000

CHRYSANTHI SARDELI

EDUCATION

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS